Agency Information Collection Activities: Proposed Collection: Comment Request, 10747-10748 [E9-5292]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 47 / Thursday, March 12, 2009 / Notices
conduct during advisory committee
meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: March 3, 2009.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9–5288 Filed 3–11–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Ophthalmic Devices Panel of the
Medical Devices Advisory Committee;
Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
cprice-sewell on PRODPC61 with NOTICES
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Ophthalmic
Devices Panel of the Medical Devices
Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on March 27, 2009, from 8 a.m. to
5 p.m.
Location: Hilton Washington DC
North/Gaithersburg, Salons A, B, and C,
620 Perry Pkwy., Gaithersburg, MD.
Contact Person: James Swink, Center
for Devices and Radiological Health
(HFZ–450), Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850, 240–276–4050, or
FDA Advisory Committee Information
Line, 1–800–741–8138 (301–443–0572
in the Washington, DC area), code
3014512396. Please call the Information
Line for up-to-date information on this
meeting. A notice in the Federal
Register about last minute modifications
that impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
should always check the agency’s Web
site and call the appropriate advisory
committee hot line/phone line to learn
about possible modifications before
coming to the meeting.
Agenda: The committee will discuss,
make recommendations, and vote on a
premarket approval application,
VerDate Nov<24>2008
14:56 Mar 11, 2009
Jkt 217001
sponsored by VisionCare Technologies,
Inc., for an implantable miniature
telescope (IMTTM). The IMTTM is
indicated for monocular implant in
patients greater than 65 years of age
with stable moderate to profound
central vision impairment, i.e., distance
BCVA of 20/80 to 20/800, due to
bilateral central scotomas associated
with end-stage macular degeneration,
defined as retinal findings of geographic
atrophy or disciform scar, with foveal
involvement as determined by
fluorescein angiography and evidence of
cataract.
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/ohrms/
dockets/ac/acmenu.htm, click on the
year 2009 and scroll down to the
appropriate advisory committee link.
Procedure: Interested persons may
present data, information, or views,
orally or in writing, on issues pending
before the committee. Written
submissions may be made to the contact
person on or before March 20, 2009.
Oral presentations from the public will
be scheduled between approximately
9:30 a.m. and 10 a.m., and between
approximately 3:30 p.m. and 4 p.m.
Those desiring to make formal oral
presentations should notify the contact
person and submit a brief statement of
the general nature of the evidence or
arguments they wish to present, the
names and addresses of proposed
participants, and an indication of the
approximate time requested to make
their presentation on or before March
18, 2009. Time allotted for each
presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by March 19, 2009.
Persons attending FDA’s advisory
committee meetings are advised that the
agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
10747
require special accommodations due to
a disability, please contact AnnMarie
Williams, Conference Management staff,
at 240–276–8932, at least 7 days in
advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/oc/advisory/
default.htm for procedures on public
conduct during advisory committee
meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5
U.S.C. app. 2).
Dated: March 3, 2009.
Randall W. Lutter,
Deputy Commissioner for Policy.
[FR Doc. E9–5303 Filed 3–11–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Agency Information Collection
Activities: Proposed Collection:
Comment Request
In compliance with the requirement
for opportunity for public comment on
proposed data collection projects
(section 3506(c)(2)(A) of Title 44, United
States Code, as amended by the
Paperwork Reduction Act of 1995, Pub.
L. 104–13), the Health Resources and
Services Administration (HRSA)
publishes periodic summaries of
proposed projects being developed for
submission to the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and draft instruments, e-mail
paperwork@hrsa.gov or call the HRSA
Reports Clearance Officer on (301) 443–
1129.
Comments are invited on: (a) The
proposed collection of information for
the proper performance of the functions
of the agency; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology.
E:\FR\FM\12MRN1.SGM
12MRN1
10748
Federal Register / Vol. 74, No. 47 / Thursday, March 12, 2009 / Notices
Proposed Project: The Health
Professions Student Loan (HPSL) and
Nursing Student Loan (NSL) Programs:
Forms (OMB No. 0915–0044): Extension
The HPSL Program provides longterm, low-interest loans to students
attending schools of medicine,
osteopathic medicine, dentistry,
veterinary medicine, optometry,
podiatric medicine, and pharmacy. The
NSL Program provides long-term, lowinterest loans to students who attend
eligible schools of nursing in programs
leading to a diploma in nursing, and an
associate degree, a baccalaureate degree,
or a graduate degree in nursing.
Participating HPSL and NSL schools are
responsible for determining eligibility of
applicants, making loans, and collecting
monies owed by borrowers on their
outstanding loans. The deferment form
(HRSA Form 519) provides the schools
with documentation of a borrower’s
eligibility for deferment. The Annual
Operating Report (AOR–HRSA Form
Responses
per
respondent
Number of
respondents
Form
501) provides the Federal Government
with information from participating and
non-participating schools (schools that
are no longer granting loans but are
required to report and maintain program
records, student records, and repayment
records until all student loans are repaid
in full and all monies due the Federal
Government are returned) relating to
HPSL and NSL program operations and
financial activities.
The estimate of burden is as follows:
Total
responses
Hours per
response
Total burden
hours
Deferment HRSA–519 .......................................................
AOR–HRSA–501 ...............................................................
2,011
907
1
1
2,011
907
0.166
4
334
3,628
Total ............................................................................
2,918
........................
2,918
..........................
3,962
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by email to OIRA_submission@omb.eop.gov
or by fax to 202–395–6974. Please direct
all correspondence to the ‘‘attention of
the desk officer for HRSA.’’
Dated: March 5, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and
Coordination.
[FR Doc. E9–5292 Filed 3–11–09; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
cprice-sewell on PRODPC61 with NOTICES
Center For Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel. Genes,
Genetics, Genomics.
VerDate Nov<24>2008
14:56 Mar 11, 2009
Jkt 217001
Date: March 23–24, 2009.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Mary P. McCormick, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2208,
MSC 7890, Bethesda, MD 20892. 301/435–
1047. mccormim@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Population
and Behavioral Studies in HIV/AIDS.
Date: March 26–27, 2009.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shiv A. Prasad, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892. 301–443–
5779. prasads@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Mechanisms
of Exercise Effects.
Date: March 26, 2009.
Time: 12 p.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: Maribeth Champoux, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
MSC 7848, Bethesda, MD 20892. 301–594–
3163. champoum@csr.nih.gov.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 3 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–4991 Filed 3–11–09; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences, Special Emphasis
Panel Sites and Mechanisms of Inhaled
Anesthetic Actions.
Date: March 27, 2009.
Time: 11 a.m. to 3:30 p.m.
E:\FR\FM\12MRN1.SGM
12MRN1
]]>Agencies
[Federal Register Volume 74, Number 47 (Thursday, March 12, 2009)]
[Notices]
[Pages 10747-10748]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-5292]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Agency Information Collection Activities: Proposed Collection:
Comment Request
In compliance with the requirement for opportunity for public
comment on proposed data collection projects (section 3506(c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Pub. L. 104-13), the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
being developed for submission to the Office of Management and Budget
(OMB) under the Paperwork Reduction Act of 1995. To request more
information on the proposed project or to obtain a copy of the data
collection plans and draft instruments, e-mail paperwork@hrsa.gov or
call the HRSA Reports Clearance Officer on (301) 443-1129.
Comments are invited on: (a) The proposed collection of information
for the proper performance of the functions of the agency; (b) the
accuracy of the agency's estimate of the burden of the proposed
collection of information; (c) ways to enhance the quality, utility,
and clarity of the information to be collected; and (d) ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology.
[[Page 10748]]
Proposed Project: The Health Professions Student Loan (HPSL) and
Nursing Student Loan (NSL) Programs: Forms (OMB No. 0915-0044):
Extension
The HPSL Program provides long-term, low-interest loans to students
attending schools of medicine, osteopathic medicine, dentistry,
veterinary medicine, optometry, podiatric medicine, and pharmacy. The
NSL Program provides long-term, low-interest loans to students who
attend eligible schools of nursing in programs leading to a diploma in
nursing, and an associate degree, a baccalaureate degree, or a graduate
degree in nursing. Participating HPSL and NSL schools are responsible
for determining eligibility of applicants, making loans, and collecting
monies owed by borrowers on their outstanding loans. The deferment form
(HRSA Form 519) provides the schools with documentation of a borrower's
eligibility for deferment. The Annual Operating Report (AOR-HRSA Form
501) provides the Federal Government with information from
participating and non-participating schools (schools that are no longer
granting loans but are required to report and maintain program records,
student records, and repayment records until all student loans are
repaid in full and all monies due the Federal Government are returned)
relating to HPSL and NSL program operations and financial activities.
The estimate of burden is as follows:
----------------------------------------------------------------------------------------------------------------
Number of Responses per Total Hours per Total burden
Form respondents respondent responses response hours
----------------------------------------------------------------------------------------------------------------
Deferment HRSA-519.............. 2,011 1 2,011 0.166 334
AOR-HRSA-501.................... 907 1 907 4 3,628
-------------------------------------------------------------------------------
Total....................... 2,918 .............. 2,918 .............. 3,962
----------------------------------------------------------------------------------------------------------------
Written comments and recommendations concerning the proposed
information collection should be sent within 30 days of this notice to
the desk officer for HRSA, either by e-mail to OIRA_
submission@omb.eop.gov or by fax to 202-395-6974. Please direct all
correspondence to the ``attention of the desk officer for HRSA.''
Dated: March 5, 2009.
Alexandra Huttinger,
Director, Division of Policy Review and Coordination.
[FR Doc. E9-5292 Filed 3-11-09; 8:45 am]
BILLING CODE 4165-15-P
